Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K
Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

5.1K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.1K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

1.7K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On pethidine: The 'accidental' opioid that became a 'model' analgesic agent.

Anaesthesia and intensive care·2026
Same author

First British and Irish Press Reports of Surgical Etherization.

Anesthesia and analgesia·2024
Same author

The First Etherization in England: New Research Regarding the Identity of the First Patient, Miss Lonsdale.

Anesthesia and analgesia·2024
Same author

The First Etherization in England: Events Surrounding the Case of Miss Lonsdale.

Anesthesia and analgesia·2023
Same author

Letter to the editor about reporting drug concentrations and pharmacokinetics in regional anesthesia and pain medicine.

Regional anesthesia and pain medicine·2023
Same author

Evidence-based circumcision policy for Australia.

Journal of men's health·2022

Related Experiment Video

Updated: May 4, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

769

(Re)introducing medicinal cannabis.

Laurence E Mather1, Evert R Rauwendaal2, Vivienne L Moxham-Hall3

  • 1Sydney Medical School, University of Sydney, Sydney, NSW, Australia. lmather@med.usyd.edu.au.

The Medical Journal of Australia
|December 17, 2013
PubMed
Summary
This summary is machine-generated.

Medicinal cannabis shows genuine therapeutic value for specific neuropathic conditions, with manageable side effects. Despite committee recommendations for its availability, the NSW Government rejected this compassionate approach.

More Related Videos

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

922
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K

Related Experiment Videos

Last Updated: May 4, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

769
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

922
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K

Area of Science:

  • Pharmacology and Therapeutics
  • Neurology
  • Public Health Policy

Background:

  • Extensive scientific and medical evidence supports the medicinal utility of cannabis.
  • Focus has largely been on recreational use hazards, overshadowing potential therapeutic benefits.
  • Neuropathic conditions represent a key area where cannabis may offer therapeutic advantages.

Purpose of the Study:

  • To evaluate the scientific and medical evidence for medicinal cannabis.
  • To assess the risks and benefits of cannabis pharmacotherapy for selected conditions.
  • To inform policy recommendations regarding the availability of medicinal cannabis.

Main Methods:

  • Review of extensive scientific and medical evidence by a New South Wales Legislative Council committee.
  • Consideration of patient outcomes, including efficacy and side effect profiles.
  • Analysis of the societal and research focus on cannabis use.

Main Results:

  • Cannabis demonstrates genuine medicinal utility for certain neuropathic conditions.
  • Associated risks are acceptable, with side effects being predominantly mild.
  • Potential medical benefits have been largely overlooked in favor of concerns about recreational use.

Conclusions:

  • A multiparty committee recommended lawful availability of medicinal cannabis for selected pharmacotherapy.
  • The committee's unanimous and compassionate recommendations were dismissed by the NSW Government.
  • There is a significant disconnect between scientific evidence and public health policy regarding medicinal cannabis.